Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline ointment added to non-surgical periodontal therapy in patients with periodontitis and type 2 diabetes
ChiCTR2600134932Phase 4Not yet recruiting
- Sponsor
- Ziyang Yanjiang District People's Hospital
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of minocycline in periodontitis and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Ziyang Yanjiang District People's Hospital. Primary endpoint: glycated hemoglobin. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
minocycline
03
Conditions
periodontitistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2600134932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134932.